PL1678162T3 - Inhibitor glikoproteiny P, metoda jego wytwarzania i kompozycja farmaceutyczna go zawierająca - Google Patents
Inhibitor glikoproteiny P, metoda jego wytwarzania i kompozycja farmaceutyczna go zawierającaInfo
- Publication number
- PL1678162T3 PL1678162T3 PL04774778T PL04774778T PL1678162T3 PL 1678162 T3 PL1678162 T3 PL 1678162T3 PL 04774778 T PL04774778 T PL 04774778T PL 04774778 T PL04774778 T PL 04774778T PL 1678162 T3 PL1678162 T3 PL 1678162T3
- Authority
- PL
- Poland
- Prior art keywords
- same
- pharmaceutical composition
- preparing
- glycoprotein inhibitor
- anticancer agent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Ceramic Engineering (AREA)
- Health & Medical Sciences (AREA)
- Manufacturing & Machinery (AREA)
- General Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Structural Engineering (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020030069582A KR100557093B1 (ko) | 2003-10-07 | 2003-10-07 | 다약제 내성 저해 활성을 갖는 테트라졸 유도체 및 그의제조방법 |
| PCT/KR2004/002550 WO2005033097A1 (en) | 2003-10-07 | 2004-10-06 | P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| EP04774778A EP1678162B1 (en) | 2003-10-07 | 2004-10-06 | P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1678162T3 true PL1678162T3 (pl) | 2010-09-30 |
Family
ID=36500896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04774778T PL1678162T3 (pl) | 2003-10-07 | 2004-10-06 | Inhibitor glikoproteiny P, metoda jego wytwarzania i kompozycja farmaceutyczna go zawierająca |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7625926B2 (pl) |
| EP (1) | EP1678162B1 (pl) |
| JP (1) | JP4481992B2 (pl) |
| KR (1) | KR100557093B1 (pl) |
| CN (1) | CN1863795B (pl) |
| AT (1) | ATE466008T1 (pl) |
| AU (1) | AU2004277475B2 (pl) |
| BR (1) | BRPI0415053B8 (pl) |
| CA (1) | CA2541301C (pl) |
| DE (1) | DE602004026903D1 (pl) |
| DK (1) | DK1678162T3 (pl) |
| ES (1) | ES2342290T3 (pl) |
| HK (1) | HK1096399A1 (pl) |
| IL (1) | IL174665A (pl) |
| MX (1) | MXPA06003803A (pl) |
| NO (1) | NO336127B1 (pl) |
| NZ (1) | NZ546257A (pl) |
| PL (1) | PL1678162T3 (pl) |
| PT (1) | PT1678162E (pl) |
| RU (1) | RU2317985C1 (pl) |
| SI (1) | SI1678162T1 (pl) |
| WO (1) | WO2005033097A1 (pl) |
| ZA (1) | ZA200603538B (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0700773D0 (en) * | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| CA2679659C (en) * | 2007-03-01 | 2016-01-19 | Novartis Ag | Pim kinase inhibitors and methods of their use |
| GB0706072D0 (en) * | 2007-03-28 | 2007-05-09 | Sterix Ltd | Compound |
| PL2344474T3 (pl) | 2008-09-02 | 2016-03-31 | Novartis Ag | Pochodne pikolinamidu jako inhibitory kinaz |
| KR101466245B1 (ko) * | 2010-01-15 | 2014-12-01 | 한미사이언스 주식회사 | 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물 |
| BR112014028954A2 (pt) | 2012-05-21 | 2017-07-18 | Novartis Ag | amidas de n-piridinila substituídas no anel como inibidores da quinase |
| KR101986683B1 (ko) * | 2012-12-13 | 2019-06-10 | 한미약품 주식회사 | 테트라졸 유도체를 활성 성분으로 포함하는 용해도가 개선된 고체 분산체 |
| CN103804352B (zh) * | 2014-01-23 | 2017-06-13 | 中国药科大学 | 三氮唑苯乙基四氢异喹啉类化合物及其制备方法和应用 |
| KR20150135110A (ko) * | 2014-05-23 | 2015-12-02 | 한미정밀화학주식회사 | p-당단백질의 저해제 및 p-당단백질의 기질 약물을 포함하는 약제학적 조성물 |
| CN104327046B (zh) * | 2014-10-14 | 2017-11-17 | 中国药科大学 | 三氮唑‑n‑乙基四氢异喹啉类化合物及其制备方法和应用 |
| JO3737B1 (ar) * | 2015-07-21 | 2021-01-31 | Athenex Therapeutics Ltd | تركيبات علاجية من باكليتاكسيل تعطى عن طريق الفم ومثبط P-gp لعلاج السرطان |
| TWI715636B (zh) | 2015-09-30 | 2021-01-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
| EP3773581A4 (en) * | 2018-04-13 | 2021-12-29 | Athenex Therapeutics Limited | Therapeutic combinations of orally administered paclitaxel and a p-gp inhibitor for the treatment of angiosarcoma |
| EP3893867A1 (en) | 2018-12-14 | 2021-10-20 | Athenex HK Innovative Limited | Therapeutic combinations of orally administered docetaxel and a p-gp inhibitor for the treatment of cancer |
| CN113631166A (zh) * | 2018-12-14 | 2021-11-09 | 慧源香港创新有限公司 | 用于治疗癌症的口服给药的伊立替康和P-gp抑制剂的治疗组合 |
| WO2020168144A1 (en) | 2019-02-14 | 2020-08-20 | Teva Pharmaceuticals International Gmbh | Solid state forms of n-[2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-2(lh)- isoquinolinyl)ethyl] phenyl }-2h-tetrazol-5-yl)-4,5-dimethoxyphenyl] -4- oxo-4h-chromene-2-carboxamide and of its mesylate salt |
| WO2020230037A1 (en) * | 2019-05-13 | 2020-11-19 | Dr. Reddy's Laboratories Limited | Alternate process for the preparation of encequidar |
| WO2021044350A1 (en) * | 2019-09-04 | 2021-03-11 | Dr. Reddy’S Laboratories Limited | Solid forms of encequidar mesylate and processes thereof |
| WO2022011221A1 (en) | 2020-07-10 | 2022-01-13 | Teva Czech Industries S.R.O | Solid state forms of n-[2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-2(1h)-isoquinolinyl)ethyl]phenyl}-2h-tetrazol-5-yl)-4,5-dimethoxyphenyl]-4-oxo-4h-chromene-2-carboxamide mesylate salt |
| IL301516A (en) | 2020-10-07 | 2023-05-01 | Athenex Inc | Acetamido-phenyltetrazol derivatives and methods of using them |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2074867T3 (es) | 1990-11-06 | 1995-09-16 | Pfizer | Derivados de quinazolina para potenciar la actividad antitumoral. |
| JP3223193B2 (ja) * | 1991-08-09 | 2001-10-29 | 株式会社日清製粉グループ本社 | インドール誘導体およびそれらを有効成分とする抗癌剤耐性克服物質 |
| ES2103479T3 (es) | 1992-07-10 | 1997-09-16 | Glaxo Lab Sa | Derivados de anilida. |
| GB9717576D0 (en) * | 1997-08-19 | 1997-10-22 | Xenova Ltd | Pharmaceutical compounds |
| EP1256341A4 (en) * | 2000-02-15 | 2004-12-08 | Teijin Ltd | ANTI-CANCER MEDICINAL PRODUCT COMPRISING AN ANTHRANILIC ACID DERIVATIVE AS AN ACTIVE INGREDIENT |
| DE60326341D1 (de) | 2002-05-14 | 2009-04-09 | Xenova Ltd | Verfahren zur herstellung von anthranilsäurederivat-hydrat |
| KR100580743B1 (ko) | 2003-10-08 | 2006-05-15 | 한미약품 주식회사 | 다약제 내성 저해 활성을 갖는 신규한 크로몬 유도체 또는이의 약제학적으로 허용가능한 염 및 이들의 제조 방법 |
-
2003
- 2003-10-07 KR KR1020030069582A patent/KR100557093B1/ko active IP Right Grant
-
2004
- 2004-10-06 CA CA002541301A patent/CA2541301C/en active Active
- 2004-10-06 PT PT04774778T patent/PT1678162E/pt unknown
- 2004-10-06 SI SI200431434T patent/SI1678162T1/sl unknown
- 2004-10-06 MX MXPA06003803A patent/MXPA06003803A/es active IP Right Grant
- 2004-10-06 RU RU2006114427/04A patent/RU2317985C1/ru active
- 2004-10-06 US US10/574,098 patent/US7625926B2/en active Active
- 2004-10-06 AU AU2004277475A patent/AU2004277475B2/en active Active
- 2004-10-06 PL PL04774778T patent/PL1678162T3/pl unknown
- 2004-10-06 CN CN2004800293562A patent/CN1863795B/zh active Active
- 2004-10-06 WO PCT/KR2004/002550 patent/WO2005033097A1/en active IP Right Grant
- 2004-10-06 DE DE602004026903T patent/DE602004026903D1/de active Active
- 2004-10-06 JP JP2006532094A patent/JP4481992B2/ja active Active
- 2004-10-06 ES ES04774778T patent/ES2342290T3/es active Active
- 2004-10-06 DK DK04774778.7T patent/DK1678162T3/da active
- 2004-10-06 BR BRPI0415053A patent/BRPI0415053B8/pt active IP Right Grant
- 2004-10-06 EP EP04774778A patent/EP1678162B1/en active Active
- 2004-10-06 AT AT04774778T patent/ATE466008T1/de active
- 2004-10-06 NZ NZ546257A patent/NZ546257A/en unknown
-
2006
- 2006-03-30 IL IL174665A patent/IL174665A/en active IP Right Grant
- 2006-05-04 ZA ZA200603538A patent/ZA200603538B/xx unknown
- 2006-05-05 NO NO20062019A patent/NO336127B1/no unknown
-
2007
- 2007-04-13 HK HK07103870.2A patent/HK1096399A1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1096399A1 (en) | P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same p- | |
| MXPA05009985A (es) | Ligandos de receptores de canabinoides. | |
| EP1714961A4 (en) | INDAZOL COMPOUND AND THEIR PHARMACEUTICAL USE | |
| UA96449C2 (en) | Stable laquinimod preparations | |
| GB9914486D0 (en) | Medicaments | |
| ATE450533T1 (de) | Carboxamidderivate | |
| MXPA04005877A (es) | Composiciones farmaceuticas de derivados de taxano oralmente activos con biodisponibilidad mejorada. | |
| TW200833370A (en) | Pharmaceutical composition containing low substituted hydroxypropylcellulose | |
| WO2005117895A8 (en) | Compositions comprising meloxicam | |
| TNSN06220A1 (en) | Benzimidazole derivatives | |
| EP1839662A4 (en) | ANTITUMOR AGENT | |
| MXPA03010761A (es) | Combinaciones farmaceuticas. | |
| GB0109122D0 (en) | Novel compounds | |
| AU2003239389A1 (en) | Opioid receptor antagonists | |
| UA86776C2 (ru) | Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение | |
| WO2004071374A3 (en) | Once a day orally administered pharmaceutical compositions | |
| AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
| WO2005013935A3 (en) | Composition for releasing a weak base for an extended period of time | |
| WO2003089449A3 (fr) | Composes aminoalkylsteroles avec activite anti-tumeur et neuroprotective | |
| WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
| TW200510370A (en) | Urea derivatives | |
| TW200626567A (en) | Benzoxazine and quinoxaline derivatives and uses | |
| AU2003281468A1 (en) | P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient | |
| AU2001244999A1 (en) | Naphthamide neurokinin antagonists for use as medicaments | |
| WO2006053778A3 (en) | Amide derivatives, their manufacture and use as pharmaceutical agents |